Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Furst

Showing results (461-470 of 755) with videos related to

Pageof 76
Sort By:
Annals of the Rheumatic Diseases|August 31, 2021
Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome shared megakaryocyte expansion in peripheral bloodYukai Wang, Xuezhen Xie, Chengpeng Zhang, et al.
The Lancet. Rheumatology|January 22, 2024
The role of skin ultrasound in systemic sclerosis: looking below the surface to understand disease evolutionGemma Lepri, Michael Hughes, Yannick Allanore, et al.
The Journal of Rheumatology|April 17, 2017
Structural Validity of the Rheumatology Attitudes Index in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life StudyShadi Gholizadeh, Sarah D Mills, Rina S Fox, et al.
Seminars in Arthritis and Rheumatism|December 12, 2013
Proceedings of the 5th annual perspectives in rheumatic diseasesDaniel E Furst, Brian Mandell, Leonard H Calabrese, et al.
Journal of Clinical Pharmacology|February 1, 1994
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Rheumatology (Oxford, England)|August 22, 2006
Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosisO Distler, F Behrens, D Huscher, et al.
Clinical Pharmacology and Therapeutics|April 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Journal of Pharmaceutical Sciences|June 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Arthritis and Rheumatism|January 16, 2003
Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trialMichael E Weinblatt, Edward C Keystone, Daniel E Furst, et al.
Rheumatology (Oxford, England)|December 2, 2004
HLA allelic variants encoding DR11 in diffuse and limited systemic sclerosis in Caucasian womenL S Loubière, N C Lambert, M M Madeleine, et al.
Pageof 76

Showing results (461-470 of 755) with videos related to

Sort By:
Pageof 76
Annals of the Rheumatic Diseases|August 31, 2021
Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome shared megakaryocyte expansion in peripheral bloodYukai Wang, Xuezhen Xie, Chengpeng Zhang, et al.
The Lancet. Rheumatology|January 22, 2024
The role of skin ultrasound in systemic sclerosis: looking below the surface to understand disease evolutionGemma Lepri, Michael Hughes, Yannick Allanore, et al.
The Journal of Rheumatology|April 17, 2017
Structural Validity of the Rheumatology Attitudes Index in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life StudyShadi Gholizadeh, Sarah D Mills, Rina S Fox, et al.
Seminars in Arthritis and Rheumatism|December 12, 2013
Proceedings of the 5th annual perspectives in rheumatic diseasesDaniel E Furst, Brian Mandell, Leonard H Calabrese, et al.
Journal of Clinical Pharmacology|February 1, 1994
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Rheumatology (Oxford, England)|August 22, 2006
Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosisO Distler, F Behrens, D Huscher, et al.
Clinical Pharmacology and Therapeutics|April 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Journal of Pharmaceutical Sciences|June 1, 1992
Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentC C Peck, W H Barr, L Z Benet, et al.
Arthritis and Rheumatism|January 16, 2003
Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trialMichael E Weinblatt, Edward C Keystone, Daniel E Furst, et al.
Rheumatology (Oxford, England)|December 2, 2004
HLA allelic variants encoding DR11 in diffuse and limited systemic sclerosis in Caucasian womenL S Loubière, N C Lambert, M M Madeleine, et al.
Pageof 76